Found 8 matching trials
Bioavailability of LY03004 and Risperdal® Consta®
PHASE1This study is to assess the bioavailability of LY03004 compared to Risperda...
Location
Woodland International
An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
PHASE1A review of the amount of drug in your blood over time....
Location
Neuropsychiatric Research Center of Orange County
Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
PHASE4The purpose of this study is to compare the effectiveness of two antipsycho...
Location
Multiple Locations
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)
N/AThe objectives of this study are to describe characteristics, treatment pat...
Location
Alkermes Investigational Site
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
PHASE4The purpose of the study is to evaluate the maintained effectiveness of lon...
Location
Multiple Locations
Risperdal Consta for Bipolar Disorder
PHASE3We recruited 50 consenting adult subjects with DSM-IV TR diagnoses of bipol...
Location
Mayview State Hospital
A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
PHASE3The purpose of this study is to determine the safety and effectiveness of a...
Location
Multiple Locations
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
PHASE1This is an open-label, multiple dose, PK and safety study in patients with ...
Location
Collaborative Neuroscience Network